Jéssica Guimarães Rodrigues de Roure

Jéssica Guimarães Rodrigues de Roure

Auto-generated profile, based on publicly available information

Jéssica Guimarães Rodrigues de Roure

University of Brasília, Faculty of Medicine, BRASÍLIA, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
LFLoyane Barbosa dos Santos Furtado
Loyane Barbosa dos Santos Furtado
Iel Marciano de Moraes FilhoIel Marciano de Moraes Filho
Iel Marciano de Moraes Filho
TSThais Vilela de Sousa
Thais Vilela de Sousa
JRJéssica Guimarães Rodrigues de Roure
Jéssica Guimarães Rodrigues de Roure
TLThaís Pereira Lima
Thaís Pereira Lima
FFFrancidalma Soares Sousa Carvalho Filha
Francidalma Soares Sousa Carvalho Filha
Objetivo: Descrever o desempenho do enfermeiro no processo de morte encefálica e na doação de órgãos e tecidos. Método: Trata-se de um estudo de revisão narrativa da literatura com abordagem qualitativa exploratória voltada para atuação do enfermeiro em casos de morte encefálica e doação de órgãos. Resultados: Foram selecionados 14 artigos de acordo com o tema, após a interpretação foram divididos em duas categorias: a conduta da enfermagem frente ao possível doador com morte encefálica e diante a família dos pacientes com morte encefálica. Conclusão: O enfermeiro se apresenta como um otimizador de todo o processo de doação de órgãos e tecidos, ademais de ter um papel importante na busca ativa e na manutenção de pacientes com morte encefálica, além de se articular com os familiares na tentativa de obter uma decisão favorável à doação. A entrevista de enfermagem mostrou-se como um instrumento preditor que, se direcionado de maneira efetiva e humanizada, é capaz de evitar uma recusa familiar na tomada de decisão frente à doação.

18 June 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
MDMarvery Duarte*
Marvery Duarte*
NMNicolle P. Marinheiro
Nicolle P. Marinheiro
OJOdimar Q. Junior
Odimar Q. Junior
ONOtávio T Nóbrega
Otávio T Nóbrega
JRJéssica G. Roure
Jéssica G. Roure
RLRicardo M. Lima
Ricardo M. Lima
Background We investigated the association between polypharmacy and sarcopenia in patients on hemodialysis. Methods Cross-sectional data from the SARC-HD study were analyzed. Patients were classified according to the number of prescribed medications as no polypharmacy (0–4), polypharmacy (5–9), and hyperpolypharmacy (≥ 10). Sarcopenia was diagnosed and staged according to the adapted EWGSOP2 consensus. Results 955 patients (48% ≥ 60 years, 61% male) were analyzed. Polypharmacy and hyperpolypharmacy were observed in 50% and 26% of patients, respectively. Patients with hyperpolypharmacy had poorer physical function compared to the no polypharmacy group. Low muscle strength was found in 45%, while sarcopenia (confirmed and severe stages) in 21% of the cohort. Patients in the polypharmacy groups had higher prevalence of low muscle strength, but similar sarcopenia rates to those in the no polypharmacy group. Only hyperpolypharmacy was independently associated with low muscle strength (64% higher adjusted odds, 95% CI 1.10–2.46), whereas no significant associations were observed with sarcopenia. Also, each addition of two medications was independently associated with 10% higher adjusted odds (95% CI 1.02–1.20) of low muscle strength. Conclusions In patients on hemodialysis, the number of medications and hyperpolypharmacy were independently associated with low muscle strength, but not with sarcopenia per se.

21 March 2026 in Journal of Renal Nutrition
Verified
Journal Article
Open access
MDMarvery Duarte*
Marvery Duarte*
ONOtávio T Nóbrega
Otávio T Nóbrega
AGAna C. Grangeiro
Ana C. Grangeiro
DMDanielle C. Moreira
Danielle C. Moreira
JRJéssica G. Roure
Jéssica G. Roure
BVBarbara P. Vogt
Barbara P. Vogt
This study investigated the association between cognitive dysfunction and sarcopenia in patients on hemodialysis. This is a cross-sectional analysis of the XXX study. Cognitive function was assessed using the Mini-Mental State Examination, adjusted for literacy level. Patients were categorized with normal cognition, mild-to-moderate dysfunction, or severe cognitive dysfunction. Sarcopenia was diagnosed and staged according to an adapted EWGSOP2 criteria, assessing handgrip strength or sit-to-stand test, calf circumference, and usual gait speed. For regression analyses (adjusted for clinically relevant confounders), confirmed and severe sarcopenia stages were combined into a binary outcome. A total of 946 patients were analyzed (48% ≥60 years, 61% male, and median dialysis vintage of 33 months). Mild-to-moderate and severe cognitive dysfunctions were observed in 38% and 18% of the cohort, respectively. Patients with cognitive dysfunction exhibited poorer physical function and lower calf circumference, higher prevalence of all sarcopenia traits, and higher rate of severe sarcopenia. In the adjusted logistic regression, only severe cognitive dysfunction was significantly associated with sarcopenia, showing 87% higher odds (adjusted odds ratio [aOR] = 1.87, 95% CI: 1.11 - 3.16) compared to the normal cognition group. In the fully adjusted model including malnutrition, this association did not remain significant (aOR = 1.55, 95% CI: 0.86 - 2.82). In patients on hemodialysis, severe cognitive dysfunction was associated with sarcopenia, although this may be mediated by malnutrition. These findings underscore the need for integrated assessment strategies targeting both cognitive and physical declines in this population.

9 November 2026 in Journal of Renal Nutrition
Verified
Journal Article
Open access
DMDário R. Mondini
Dário R. Mondini
MDMarvery P. Duarte
Marvery P. Duarte
HDHenrique S. Disessa
Henrique S. Disessa
AAAngélica N. Adamoli
Angélica N. Adamoli
DBDaiana C. Bündchen
Daiana C. Bündchen
Heitor S. RibeiroHeitor S. Ribeiro
Heitor S. Ribeiro